help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaoka, T.
Right arrow Articles by Kobayashi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaoka, T.
Right arrow Articles by Kobayashi, M.
Endocrinology Vol. 140, No. 8 3826-3834
Copyright © 1999 by The Endocrine Society


ARTICLES

Synergistic Role of the Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase Cascade in the Regulation of Insulin Receptor Trafficking1

Toshiyasu Sasaoka, Tsutomu Wada, Hajime Ishihara, Yasumitsu Takata, Tetsuro Haruta, Isao Usui, Manabu Ishiki and Masashi Kobayashi

From the First Department of Medicine, Toyama Medical & Pharmaceutical University, Toyama, 930-0194 Japan

Address all correspondence and requests for reprints to: Toshiyasu Sasaoka, M.D., Ph.D., First Department of Medicine, Toyama Medical & Pharmaceutical University, 2630 Sugitani, Toyama, 930-0194, Japan. E-mail: tsasaoka-tym{at}umin.ac.jp

To examine the molecular mechanism of insulin receptor trafficking, we investigated the intracellular signaling molecules that regulate this process in Rat1 fibroblasts overexpressing insulin receptors. Cellular localization of insulin receptors was assessed by confocal laser microscopy with indirect immunofluorescence staining. Insulin receptors were visualized diffusely in the basal state. Insulin treatment induced the change of insulin receptor localization to perinuclear compartment. This insulin-induced insulin receptor trafficking was not affected by treatment of the cells with PI3-kinase inhibitor (wortmannin), whereas treatment with MEK [mitogen-activated protein (MAP) kinase-Erk kinase] inhibitor (PD98059) partly inhibited the process in a dose-dependent manner. Interestingly, treatment with both wortmannin and PD98059 almost completely inhibited insulin receptor trafficking. The functional importance of PI3-kinase and MAP kinase in the trafficking process was directly assessed by using single cell microinjection analysis. Microinjection of p85-SH2 and/or catalytically inactive MAP kinase ([K71A]Erk1) GST fusion protein gave the same results as treatment with wortmannin and PD98059. Furthermore, to determine the crucial step for the requirement of PI3-kinase and MAP kinase pathways, the effect of wortmannin and PD98059 on insulin receptor endocytosis was studied. Insulin internalization from the plasma membrane and subsequent insulin degradation were not affected by treatment with wortmannin and PD98059. In contrast, insulin receptor down-regulation from the cell surface and insulin receptor degradation, after prolonged incubation with insulin, were markedly impaired by the treatment. These results suggest that PI3-kinase and MAP kinase pathways synergistically regulate insulin receptor trafficking at a step subsequent to the receptor internalization.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Boura-Halfon, H. Voliovitch, R. Feinstein, K. Paz, and Y. Zick
Extracellular Matrix Proteins Modulate Endocytosis of the Insulin Receptor
J. Biol. Chem., April 25, 2003; 278(18): 16397 - 16404.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. He, D. D. Browning, and R. D. Ye
Differential Roles of the NPXXY Motif in Formyl Peptide Receptor Signaling
J. Immunol., March 15, 2001; 166(6): 4099 - 4105.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. J. Carrillo, B. Ibares, A. Esteban-Gamboa, and J. E. Feliu
Involvement of Both Phosphatidylinositol 3-Kinase and p44/p42 Mitogen-Activated Protein Kinase Pathways in the Short-Term Regulation of Pyruvate Kinase L by Insulin
Endocrinology, March 1, 2001; 142(3): 1057 - 1064.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. W. Kang, J. H. Ryu, and S. G. Kim
The Essential Role of Phosphatidylinositol 3-Kinase and of p38 Mitogen-Activated Protein Kinase Activation in the Antioxidant Response Element-Mediated rGSTA2 Induction by Decreased Glutathione in H4IIE Hepatoma Cells
Mol. Pharmacol., November 1, 2000; 58(5): 1017 - 1025.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
F. Blanchard, L. Duplomb, Y. Wang, O. Robledo, E. Kinzie, V. Pitard, A. Godard, Y. Jacques, and H. Baumann
Stimulation of Leukemia Inhibitory Factor Receptor Degradation by Extracellular Signal-regulated Kinase
J. Biol. Chem., September 8, 2000; 275(37): 28793 - 28801.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T.-j. Liu, H.-c. Lai, W. Wu, S. Chinn, and P. H. Wang
Developing a Strategy to Define the Effects of Insulin-Like Growth Factor-1 on Gene Expression Profile in Cardiomyocytes
Circ. Res., June 22, 2001; 88(12): 1231 - 1238.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society